126 related articles for article (PubMed ID: 36645880)
1. Alternative splicing of FKBP5 gene exerts control over T lymphocyte expansion.
Marrone L; D'Agostino M; Cesaro E; di Giacomo V; Urzini S; Romano MF; Romano S
J Cell Biochem; 2023 Jan; ():. PubMed ID: 36645880
[TBL] [Abstract][Full Text] [Related]
2. Alternative macrophage polarisation associated with resistance to anti-PD1 blockade is possibly supported by the splicing of FKBP51 immunophilin in melanoma patients.
Troiani T; Giunta EF; Tufano M; Vigorito V; Arrigo P; Argenziano G; Ciardiello F; Romano MF; Romano S
Br J Cancer; 2020 Jun; 122(12):1782-1790. PubMed ID: 32317723
[TBL] [Abstract][Full Text] [Related]
3. Immunomodulatory pathways regulate expression of a spliced FKBP51 isoform in lymphocytes of melanoma patients.
Romano S; D'Angelillo A; Staibano S; Simeone E; D'Arrigo P; Ascierto PA; Scalvenzi M; Mascolo M; Ilardi G; Merolla F; Jovarauskaite E; Romano MF
Pigment Cell Melanoma Res; 2015 Jul; 28(4):442-52. PubMed ID: 25895097
[TBL] [Abstract][Full Text] [Related]
4. FKBP51s signature in peripheral blood mononuclear cells of melanoma patients as a possible predictive factor for immunotherapy.
Romano S; Simeone E; D'Angelillo A; D'Arrigo P; Russo M; Capasso M; Lasorsa VA; Zambrano N; Ascierto PA; Romano MF
Cancer Immunol Immunother; 2017 Sep; 66(9):1143-1151. PubMed ID: 28434031
[TBL] [Abstract][Full Text] [Related]
5. PD-L1 Expression Fluctuates Concurrently with Cyclin D in Glioblastoma Cells.
Tufano M; D'Arrigo P; D'Agostino M; Giordano C; Marrone L; Cesaro E; Romano MF; Romano S
Cells; 2021 Sep; 10(9):. PubMed ID: 34572014
[TBL] [Abstract][Full Text] [Related]
6. A regulatory role for the co-chaperone FKBP51s in PD-L1 expression in glioma.
D'Arrigo P; Russo M; Rea A; Tufano M; Guadagno E; Del Basso De Caro ML; Pacelli R; Hausch F; Staibano S; Ilardi G; Parisi S; Romano MF; Romano S
Oncotarget; 2017 Sep; 8(40):68291-68304. PubMed ID: 28978117
[TBL] [Abstract][Full Text] [Related]
7. Scaffold proteins of cancer signaling networks: The paradigm of FK506 binding protein 51 (FKBP51) supporting tumor intrinsic properties and immune escape.
Marrone L; D'Agostino M; Giordano C; Giacomo VD; Urzini S; Malasomma C; Gammella MP; Tufano M; Romano S; Romano MF
Oncol Res; 2023; 31(4):423-436. PubMed ID: 37415743
[TBL] [Abstract][Full Text] [Related]
8. FKBP51 mediates resilience to inflammation-induced anxiety through regulation of glutamic acid decarboxylase 65 expression in mouse hippocampus.
Gan YL; Wang CY; He RH; Hsu PC; Yeh HH; Hsieh TH; Lin HC; Cheng MY; Jeng CJ; Huang MC; Lee YH
J Neuroinflammation; 2022 Jun; 19(1):152. PubMed ID: 35705957
[TBL] [Abstract][Full Text] [Related]
9. The splicing FK506-binding protein-51 isoform plays a role in glioblastoma resistance through programmed cell death ligand-1 expression regulation.
D'Arrigo P; Digregorio M; Romano S; Tufano M; Rea A; Hausch F; Dedobbeleer M; Vigorito V; Russo S; Bauder M; Rogister B; Romano MF
Cell Death Discov; 2019; 5():137. PubMed ID: 31583120
[TBL] [Abstract][Full Text] [Related]
10. FKBP51 increases the tumour-promoter potential of TGF-beta.
Romano S; D'Angelillo A; D'Arrigo P; Staibano S; Greco A; Brunetti A; Scalvenzi M; Bisogni R; Scala I; Romano MF
Clin Transl Med; 2014 Jan; 3(1):1. PubMed ID: 24460977
[TBL] [Abstract][Full Text] [Related]
11. Modulating FKBP5/FKBP51 and autophagy lowers HTT (huntingtin) levels.
Bailus BJ; Scheeler SM; Simons J; Sanchez MA; Tshilenge KT; Creus-Muncunill J; Naphade S; Lopez-Ramirez A; Zhang N; Lakshika Madushani K; Moroz S; Loureiro A; Schreiber KH; Hausch F; Kennedy BK; Ehrlich ME; Ellerby LM
Autophagy; 2021 Dec; 17(12):4119-4140. PubMed ID: 34024231
[TBL] [Abstract][Full Text] [Related]
12. Decidual cell FKBP51-progesterone receptor binding mediates maternal stress-induced preterm birth.
Guzeloglu-Kayisli O; Semerci N; Guo X; Larsen K; Ozmen A; Arlier S; Mutluay D; Nwabuobi C; Sipe B; Buhimschi I; Buhimschi C; Schatz F; Kayisli UA; Lockwood CJ
Proc Natl Acad Sci U S A; 2021 Mar; 118(11):. PubMed ID: 33836562
[TBL] [Abstract][Full Text] [Related]
13. FKBP51, a novel T-cell-specific immunophilin capable of calcineurin inhibition.
Baughman G; Wiederrecht GJ; Campbell NF; Martin MM; Bourgeois S
Mol Cell Biol; 1995 Aug; 15(8):4395-402. PubMed ID: 7542743
[TBL] [Abstract][Full Text] [Related]
14. FKBP51 Contributes to Uterine Leiomyoma Pathogenesis by Inducing Cell Proliferation and Extracellular Matrix Deposition.
New EP; Semerci N; Ozmen A; Guo X; Jonnalagadda VA; Kim JW; Anderson ML; Guzeloglu-Kayisli O; Imudia AN; Lockwood CJ; Kayisli UA
Reprod Sci; 2022 Jun; 29(6):1939-1949. PubMed ID: 35426036
[TBL] [Abstract][Full Text] [Related]
15. FKBP5 Gene Expression Predicts Antidepressant Treatment Outcome in Depression.
Ising M; Maccarrone G; Brückl T; Scheuer S; Hennings J; Holsboer F; Turck CW; Uhr M; Lucae S
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30678080
[TBL] [Abstract][Full Text] [Related]
16. Forced overexpression of either of the two common human Foxp3 isoforms can induce regulatory T cells from CD4(+)CD25(-) cells.
Aarts-Riemens T; Emmelot ME; Verdonck LF; Mutis T
Eur J Immunol; 2008 May; 38(5):1381-90. PubMed ID: 18412171
[TBL] [Abstract][Full Text] [Related]
17. Modulation of Suppressive Activity and Proliferation of Human Regulatory T Cells by Splice-Switching Oligonucleotides Targeting FoxP3 Pre-mRNA.
Blinova VG; Gladilina YA; Abramova AA; Eliseeva DD; Vtorushina VV; Shishparenok AN; Zhdanov DD
Cells; 2023 Dec; 13(1):. PubMed ID: 38201281
[TBL] [Abstract][Full Text] [Related]
18. Age-associated epigenetic upregulation of the FKBP5 gene selectively impairs stress resiliency.
Sabbagh JJ; O'Leary JC; Blair LJ; Klengel T; Nordhues BA; Fontaine SN; Binder EB; Dickey CA
PLoS One; 2014; 9(9):e107241. PubMed ID: 25191701
[TBL] [Abstract][Full Text] [Related]
19. Dexamethasone-Induced FKBP51 Expression in CD4
Tejwani V; McCormack A; Suresh K; Woo H; Xu N; Davis MF; Brigham E; Hansel NN; McCormack MC; D'Alessio FR
Front Immunol; 2021; 12():744782. PubMed ID: 34721414
[TBL] [Abstract][Full Text] [Related]
20. Molecular Aspects of FKBP51 that Enable Melanoma Dissemination.
D'Angelillo A; Staibano S; Russo M; Romano MF; Romano S
Curr Mol Pharmacol; 2015; 9(2):141-7. PubMed ID: 25986563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
